Related references
Note: Only part of the references are listed.Gene Editing in Trypanosomatids: Tips and Tricks in the CRISPR-Cas9 Era
Akila Yagoubat et al.
TRENDS IN PARASITOLOGY (2020)
Bar-seq strategies for the LeishGEdit toolbox
Tom Beneke et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2020)
A transient CRISPR/Cas9 expression system for genome editing in Trypanosoma brucei
Sebastian Shaw et al.
BMC RESEARCH NOTES (2020)
Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kazuishi Kubota et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV
Susana Revollo et al.
PATHOGENS (2019)
Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania
Arijit Bhattacharya et al.
NATURE COMMUNICATIONS (2019)
Beyond immune escape: a variant surface glycoprotein causes suramin resistance in Trypanosoma brucei
Natalie Wiedemar et al.
MOLECULAR MICROBIOLOGY (2018)
Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes
Eva Rico et al.
SCIENTIFIC REPORTS (2018)
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms
Christopher Fernandez-Prada et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3
Richard J. Wall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Evolutionary Loss of RNAi Key Determinants in Kinetoplastids as a Multiple Sporadic Phenomenon
Andrey V. Matveyev et al.
JOURNAL OF MOLECULAR EVOLUTION (2017)
Measuring global health: motivation and evolution of the Global Burden of Disease Study
Christopher J. L. Murray et al.
LANCET (2017)
Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins
Lia Carolina Soares Medeiros et al.
MBIO (2017)
Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole
Monica C. Campos et al.
SCIENTIFIC REPORTS (2017)
Induction of allopurinol resistance in Leishmania infantum isolated from dogs
Daniel Yasur-Landau et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy
Khalid J. H. Alzahrani et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2017)
A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
Tom Beneke et al.
ROYAL SOCIETY OPEN SCIENCE (2017)
Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense
Fabrice E. Graf et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania
Elodie Gazanion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model
S. Hendrickx et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites
Lauriane Sollelis et al.
CELLULAR MICROBIOLOGY (2015)
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
Wen-Wei Zhang et al.
MBIO (2015)
CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Rteveals Their Role in Flagellar Attachment
Noelia Lander et al.
MBIO (2015)
Drug resistance analysis by next generation sequencing in Leishmania
Philippe Leprohon et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Identification and Deconvolution of Cross-Resistance Signals from Antimalarial Compounds Using Multidrug-Resistant Plasmodium falciparum Strains
Monika Chugh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi
Duo Peng et al.
MBIO (2015)
Unveiling Benznidazole's Mechanism of Action Through Overexpression of DNA Repair Proteins in Trypanosoma cruzi
Matheus Andrade Rajao et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2014)
Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert
Monica C. O. Campos et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2014)
Induced Resistance to Methionyl-tRNA Synthetase Inhibitors in Trypanosoma brucei Is Due to Overexpression of the Target
Ranae M. Ranade et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Global economic burden of Chagas disease: a computational simulation model
Bruce Y. Lee et al.
LANCET INFECTIOUS DISEASES (2013)
P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance
Monica Caroline Oliveira Campos et al.
PARASITOLOGY RESEARCH (2013)
Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis
Meghan R. Perry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
Juma A. M. Ali et al.
MOLECULAR PHARMACOLOGY (2013)
Proteomic profiling and potential cellular target identification of K11777, a clinical cysteine protease inhibitor, in Trypanosoma brucei
Peng-Yu Yang et al.
CHEMICAL COMMUNICATIONS (2012)
Parasite-Based Screening and Proteome Profiling Reveal Orlistat, an FDA-Approved Drug, as a Potential Anti Trypanosoma brucei Agent[]
Peng-Yu Yang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
Ana Maria Mejia et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
High-throughput decoding of antitrypanosomal drug efficacy and resistance
Sam Alsford et al.
NATURE (2012)
Leishmania donovani Develops Resistance to Drug Combinations
Raquel Garcia-Hernandez et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Comparative Genomics Reveals Two Novel RNAi Factors in Trypanosoma brucei and Provides Insight into the Core Machinery
Rebecca L. Barnes et al.
PLOS PATHOGENS (2012)
High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome
Sam Alsford et al.
GENOME RESEARCH (2011)
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Tim Downing et al.
GENOME RESEARCH (2011)
RNAi pathways in parasitic protists and worms
Thiago Mafra Batista et al.
JOURNAL OF PROTEOMICS (2011)
Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
Nicola Baker et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters
Gabriela Schumann Burkard et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2011)
The Diamidine Diminazene Aceturate Is a Substrate for the High-Affinity Pentamidine Transporter: Implications for the Development of High Resistance Levels in Trypanosomes
Ibrahim A. Teka et al.
MOLECULAR PHARMACOLOGY (2011)
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis
Christopher Chidley et al.
NATURE CHEMICAL BIOLOGY (2011)
Crystal Structures of T. b. rhodesiense Adenosine Kinase Complexed with Inhibitor and Activator: Implications for Catalysis and Hyperactivation
Sabine Kuettel et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach
Luke Mercer et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis
Antoaneta Y. Sokolova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cloning, characterization, and subcellular localization of a Trypanosoma cruzi argonaute protein defining a new subfamily distinctive of trypanosomatids
Maria R. Garcia Silva et al.
GENE (2010)
Retention and Loss of RNA Interference Pathways in Trypanosomatid Protozoans
Lon-Fye Lye et al.
PLOS PATHOGENS (2010)
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Isabel M. Vincent et al.
PLOS PATHOGENS (2010)
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Distinct and overlapping roles for two Dicer-like proteins in the RNA interference pathways of the ancient eukaryote Trypanosoma brucei
Kristin L. Patrick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adenosine Kinase of T. b. rhodesiense Identified as the Putative Target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine Using Chemical Proteomics
Sabine Kuettel et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection
Fabiane Matos dos Santos et al.
EXPERIMENTAL PARASITOLOGY (2008)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Target deconvolution strategies in drug discovery
Georg C. Terstappen et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance
Sonja C. Bernhard et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes
Daniel J. Bridges et al.
MOLECULAR PHARMACOLOGY (2007)
Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole
Fernanda B. Nogueira et al.
ACTA TROPICA (2006)
Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance
Charlotte A. Lanteri et al.
MOLECULAR PHARMACOLOGY (2006)
Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania
N Marquis et al.
MOLECULAR MICROBIOLOGY (2005)
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease
NM El-Sayed et al.
SCIENCE (2005)
The genome of the African trypanosome Trypanosoma brucei
M Berriman et al.
SCIENCE (2005)
Resistance as a tool for discovering and understanding targets in parasite neuromusculature
NC Sangster et al.
PARASITOLOGY (2005)
Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)
K Seifert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
E Matovu et al.
EUKARYOTIC CELL (2003)
Investigations of the metabolites of the trypanocidal drug melarsoprol
J Keiser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)